Multi-morphological biodegradable PLGE nanoparticles and their drug release behavior

Biomaterials

Volumn 30, Issue 1, 2009, Pages 100-107

  Zhang, Hanwei ^a   Bei, Jianzhong ^a   Wang, Shenguo ^a  

^a INSTITUTE OF CHEMISTRY   (China)

Author keywords

CsA drug delivery; Multi morphology; Nanoparticles (NPs); Poly(lactide co glycolide) b PEO b poly(lactide co glycolide) tri block copolymer (PLGE)

Indexed keywords

CSA DRUG DELIVERY; MULTI-MORPHOLOGY; NANOPARTICLES (NPS); POLY(LACTIDE-CO-GLYCOLIDE)-B-PEO-B-POLY(LACTIDE-CO-GLYCOLIDE) TRI-BLOCK COPOLYMER (PLGE);

ABS RESINS; BLOCK COPOLYMERS; CONTROLLED DRUG DELIVERY; DEGRADATION; ELECTRIC CURRENTS; ETHYLENE; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; NANOTECHNOLOGY; POLYETHYLENE OXIDES; POLYMERS; SPHERES; SURFACE ACTIVE AGENTS;

BIODEGRADABLE POLYMERS;

COPOLYMER; CYCLOSPORIN A; MACROGOL; NANOPARTICLE; POLYGLACTIN BLOCK MACROGOL BLOCK POLYGLACTIN; POLYGLYCOLIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL COMPOSITION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; MOLECULAR WEIGHT; PRIORITY JOURNAL;

BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; LACTIC ACID; MOLECULAR WEIGHT; NANOPARTICLES; NANOTUBES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; SPECTRUM ANALYSIS; TIME FACTORS;

EID: 53849133761     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.09.016     Document Type: Article

References (33)

1. Srivastava D., and Lee I. Nanorice and nanospears from polymer nanosphere. Adv Mater 18 (2006) 2471-2475
2. Pan J., and Feng S.S. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials 29 (2008) 2663-2672
3. Zhang H., Cui W.J., Bei J.Z., and Wang S.G. Preparation and drug release behaviors of 5-fluorouracil loaded poly(glycolide-co-lactide-co-caprolactone) nanoparticles. J Appl Polym Sci 106 (2007) 3757-3767
4. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53 (2001) 283-318
5. Williams D. The relationship between biomaterials and nanotechnology. Biomaterials 29 (2008) 1737-1738
6. TJun Y.W., Seo J.W., and Cheon J. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc Chem Res 41 2 (2008) 179-189
7. Kaur I.P., Bhandari R., Bhandari S., and Vandita K. Potential of solid lipid nanoparticles in brain targeting. J Controlled Release 127 (2008) 97-109
8. Asiyanbola B., and Soboyejo W. For the surgeon: an introduction to nanotechnology. J Surg Educ 65 (2008) 155-161
9. Gupta S., Zhang Q.L., Emrick T., and Russell T.P. "Self-corralling" nanorods under an applied electric field. Nano Lett 6 (2006) 2066-2069
10. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 68 16 (2008) 6652-6660
11. Liu D., Yang S., and Lee S.T. Preparation of novel cuprous oxide-fullerene [60] core-shell nanowires and nanoparticles via a copper (I)-assisted fullerene-polymerization reaction. J Phys Chem C 112 18 (2008) 7110-7118
12. Chen J., McLellan J.M., Siekkinen A., Xiong Y., Li Z.Y., and Xia Y. Facile synthesis of gold-silver nanocages with controllable pores on the surface. J Am Chem Soc 128 46 (2006) 14776-14777
13. Son S.J., Bai X., Nan A.J., Ghandehari H., and Lee S.B. Template synthesis of multifunctional nanotubes for controlled release. J Controlled Release 114 (2006) 143-152
14. Hilder T.A., and Hill J.M. Carbon nanotubes as drug delivery nanocapsules. Curr Appl Phys 8 (2008) 258-261
15. Maretschek S., Greiner A., and Kissel T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J Controlled Release 127 (2008) 180-187
16. Li B.Y., Rozas J., and Haynie D.T. Structural stability of polypeptide nanofilms under extreme conditions. Biotechnol Prog 22 (2006) 111-117
17. Hou S.J., Yan K., Man K., and Chan W.K. Nanosized micelles formed by the self-assembly of amphiphilic block copolymers with luminescent rhenium complexes. Langmuir 19 (2003) 2485-2490
18. Luo L.B., and Eisenberg A. Thermodynamic size control of block copolymer vesicles in solution. Langmuir 17 (2001) 6804-6811
19. Bhargava P., Zheng J.X., Li P., Quirk R., Harris F.W., and Cheng S.Z.D. Self-assembled polystyrene-block-poly(ethylene oxide) micelle morphologies in solution. Macromolecules 39 14 (2006) 4880-4888
20. Zhang L.F., and Eisenberg A. Multiple morphologies and characteristics of "crew-cut" micelle-like aggregates of polystyrene-b-poly(acrylic acid) diblock copolymers in aqueous solutions. J Am Chem Soc 118 (1996) 3168-3181
21. He C.L., Kim S.W., and Lee D.S. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Controlled Release 127 (2008) 189-207
22. Hoare T.R., and Kohane D.S. Hydrogels in drug delivery: progress and challenges. Polymer 49 (2008) 1993-2007
23. Rowlands A.S., Lim S.A., Martin D., and Cooper-White J.J. Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation. Biomaterials 28 (2007) 2109-2121
24. Hu X.X., Shen H., Yang F., Bei J.Z., and Wang S.G. Preparation and cell affinity of microtubular orientation-structured PLGA (70/30) blood vessel scaffold. Biomaterials 29 (2008) 3128-3136
25. Cai Q., Bei J.Z., Luo A.Q., and Wang S.G. Biodegradation behavior of poly(lactide-co-glycolide) induced by microorganisms. Polym Degrad Stab 71 (2001) 243-251
26. Zhao Y., Liang H.J., Wang S.G., and Wu C. Self-assembly of poly(caprolactone-b-ethylene oxide-b-caprolactone) via a microphase inversion in water. J Phys Chem B 105 4 (2001) 848-851
27. Liu L.H., Guo K., Lu J., Venkatraman S.S., Luo D., Ng K.C., et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 29 (2008) 1509-1517
28. Chung T., Wang S., and Tsai W. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly(lactide-co-glycolide) (PLGA) nanoparticles. Biomaterials 29 (2008) 228-237
29. Hua Y., Jiang X.Q., Ding Y., Zhang L.Y., Yang C.Z., Zhang J.F., et al. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials 24 (2003) 2395-2404
30. Chen D.R., Chen H.L., Bei J.Z., and Wang S.G. Morphology and biodegradation of microspheres of polyester-polyether block copolymer based on polycaprolactone/polylactide/poly(ethylene oxide). Polym Int 49 (2000) 269-276
31. Carpenter C.B. Immunosuppression in organ transplantation. N Engl J Med 322 (1990) 1224-1226
32. Wang S.G., Cai Q., Bei J.Z., Shi W.Y., and Xie L.X. An implantable immunosuppressive cyclosporine drug delivery system. Key Eng Mater 288-289 (2005) 125-128
33. Xie L.X., Shi W.Y., Wang Z.Y., Bei J.Z., and Wang S.G. Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer. Cornea 20 7 (2001) 748-752